Page last updated: 2024-08-05 11:36:09
kanamycins
null
ChEBI ID: 24951
Members (4)
| Member | Definition | Role |
|---|---|---|
| arbekacin | A kanamycin that is kanamycin B bearing an N-(2S)-4-amino-2-hydroxybutyryl group on the aminocyclitol ring. | arbekacin |
| bekanamycin | kanamycin B | |
| dibekacin | A kanamycin that is kanamycin B lacking the 3- and 4-hydroxy groups on the 2,6-diaminosugar ring. | dibekacin |
| kanamycin a | kanamycin A |
Research
Studies (7,034)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4,802 (68.27) | 18.7374 |
| 1990's | 511 (7.26) | 18.2507 |
| 2000's | 599 (8.52) | 29.6817 |
| 2010's | 864 (12.28) | 24.3611 |
| 2020's | 258 (3.67) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 250 (3.10%) | 5.53% |
| Reviews | 244 (3.03%) | 6.00% |
| Case Studies | 254 (3.15%) | 4.05% |
| Observational | 2 (0.02%) | 0.25% |
| Other | 7,303 (90.69%) | 84.16% |